Skip to main content
Jonathan Webster, MD, Oncology, Baltimore, MD

Jonathan Allen Webster MD

Hematologic Oncology


Assistant Professor

Join to View Full Profile
  • 401 North Broadway StreetWeinberg BLDGBaltimore, MD 21287

  • Phone+1 410-955-8964

  • Fax+1 410-367-2194

Dr. Webster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Medical Oncology, 2017
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2011 - 2013
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2011

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2024 - 2026
  • VA State Medical License
    VA State Medical License 2021 - 2026
  • MD State Medical License
    MD State Medical License 2014 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML
    Jonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis
    Jonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry
    Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF RegistryJune 1st, 2019

Grant Support

  • Bispecific Antibody Maintenance Therapy after Allogeneic Bone Marrow TransplantJOHNS HOPKINS UNIVERSITY2023–2028

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: